GRI BIO Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
GRI$1.89+10.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | Description | Filed Herewith | Form | Incorporated by Reference File No. | Date Filed |
|---|---|---|---|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation, as amended. | S-1 | 333-280323 | 6/20/2024 | |
| 3.2 | Amended and Restated Bylaws. | 8-K/A | 001-40034 | 5/26/2023 | |
| 4.1 | Form of Pre-Funded Warrant. | 8-K | 001-40034 | 6/27/2024 | |
| 4.2 | Form of Series C-1 Warrant. | 8-K | 001-40034 | 6/27/2024 | |
| 4.3 | Form of Series C-2 Warrant. | 8-K | 001-40034 | 6/27/2024 | |
| 4.4 | Form of Placement Agent Warrant. | 8-K | 001-40034 | 6/27/2024 | |
| 10.1 | At The Market Offering Agreement, dated May 20, 2024, by and between GRI Bio, Inc. and H.C. Wainwright & Co., LLC. | 8-K | 001-40034 | 5/20/2024 | |
| 10.2# | Amendment No. 1 to Employment Agreement, dated June 17, 2024, by and between the GRI Bio, Inc. and Albert Agro, Ph.D. | 8-K | 001-40034 | 6/18/2024 | |
| 10.3△ | Form of Securities Purchase Agreement. | 8-K | 001-40034 | 6/27/2024 | |
| 31.1 | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 31.2 | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.1* | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.2* | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 101.INS | iXBRL Instance Document | ||||
| 101.SCH | iXBRL Taxonomy Extension Schema Document | ||||
| 101.CAL | iXBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF | iXBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101.LAB | iXBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE | iXBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||
| # | Indicates a management contract or any compensatory plan, contract or arrangement. |
|---|---|
| * | This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference into such filing. |
| △ | Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company undertakes to furnish supplemental copies of any of the omitted schedules upon request by the U.S. Securities and Exchange Commission. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.